1217720-20-1 Usage
Description
RITONAVIR-D6, also known as deuterated Ritonavir, is a selective HIV protease inhibitor labeled with deuterium atoms. It is an off-white solid and is used as an internal standard for the quantification of Ritonavir by gas chromatography (GC) or liquid chromatography (LC) mass spectrometry. Additionally, it is a COVID-19-related research product.
Uses
Used in Pharmaceutical Industry:
RITONAVIR-D6 is used as an internal standard for the quantification of Ritonavir by GCor LC-mass spectrometry. It helps in accurate measurement and analysis of Ritonavir levels in various pharmaceutical formulations.
Used in COVID-19 Research:
RITONAVIR-D6 is used as a COVID-19-related research product. It aids in the study and understanding of the virus and its potential treatments.
Used in HIV Treatment:
As a deuterated selective HIV protease inhibitor, RITONAVIR-D6 plays a crucial role in the development and testing of new HIV treatments and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 1217720-20-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,7,2 and 0 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1217720-20:
(9*1)+(8*2)+(7*1)+(6*7)+(5*7)+(4*2)+(3*0)+(2*2)+(1*0)=121
121 % 10 = 1
So 1217720-20-1 is a valid CAS Registry Number.
1217720-20-1Relevant articles and documents
A method for preparing a deuterium generation of advantage holds that Wei
-
, (2018/02/04)
The invention discloses a preparation method of deuterium-labeled Ritonavir. According to the method, isobutyric acid-D6 is used as a starting raw material, and deuterium-labeled Ritonavir is synthesized through seven reactions. Optimal preparation steps and reaction conditions are screened through a lot of experiments, the whole process is reasonable in design and strong in operability; the purity of deuterium-labeled Ritonavir prepared by the preparation method provided by the invention is greater than 98 percent; the yield of the deuterium-labeled Ritonavir can be greater than 80 percent; and the isotope abundance is greater than 99 percent. The deuterium-labeled Ritonavir prepared by the preparation method provided by the invention can provide a test sample for research on metabolic mechanism of Ritonavir and has an important application value.
